Costa Rica's Emergence as a Life Sciences Powerhouse
Costa Rica continues to establish itself as a leading destination for life sciences firms, reflecting its significant growth in the medical device sector. With a wealth of resources and a strategic location, the country is becoming increasingly attractive to multinational corporations looking to expand their operations in Central America.
Participation in Major Industry Events
CINDE, along with renowned partners like BAC, Baker Tilly, and Cushman & Wakefield | AB Advisory, is set to participate in North America's premier medical device trade show, MD&M West 2025. This event is set to occur shortly, providing a platform for CINDE to showcase the competitive advantages that Costa Rica offers as a strategic hub for medical device manufacturing.
Highlighting Competitive Advantages
At MD&M West 2025, CINDE aims to promote Costa Rica's unique benefits for companies in the life sciences sector. These advantages include a highly skilled workforce, favorable business environment, and excellent infrastructure, which together create a solid foundation for the growth of medical device manufacturing.
Expanding Presence of Multinational Corporations
Recent developments highlight the ongoing expansion of global life sciences companies in Costa Rica. Notably, Harland Medical Systems has recently launched operations in the country, providing advanced manufacturing capabilities for hydrophilic coatings. This addition strengthens the existing supplier ecosystem and enhances the value chain within the medical device industry.
Innovative Growth from Leading Firms
In parallel, Edwards Lifesciences, a leader in cardiovascular disease treatments, has also broadened its reach in Costa Rica by establishing a Corporate Services Center at La Lima Business Park in Cartago. This move signifies the company's commitment to fostering innovation and furthering its operations in the region.
Impressive Growth in Medical Device Exports
Since 2017, Costa Rica has experienced a remarkable growth rate in medical device exports, averaging 18% annually. By 2024, these exports exceeded $8 billion, establishing Costa Rica as the second-largest exporter of medical devices in Latin America. This growth not only boosts the economy but also positions the country as a crucial supplier of medical devices to the United States.
About CINDE: Leading the Charge in Investment Promotion
CINDE has been a pivotal force in promoting Costa Rica as an investment destination for over 43 years. This organization collaborates with multinational companies to enhance the local business environment, supporting the establishment of more than 450 firms. Its expertise in talent development and business growth has solidified Costa Rica's status as a vital hub for life sciences.
Frequently Asked Questions
What is the significance of MD&M West 2025 for Costa Rica?
MD&M West 2025 serves as a key opportunity for Costa Rica to showcase its life sciences sector and attract investment to the region.
Which companies are expanding their operations in Costa Rica?
Companies like Harland Medical Systems and Edwards Lifesciences have recently expanded their operations in Costa Rica, highlighting the country's attractiveness for investment.
How has Costa Rica's medical device export market performed?
Since 2017, Costa Rica's medical device exports have grown significantly, surpassing $8 billion in 2024, making it a major player in Latin America.
What role does CINDE play in the life sciences sector?
CINDE actively promotes investment and supports multinational companies, contributing to the growth and development of the life sciences industry in Costa Rica.
Why is Costa Rica considered a strategic hub for medical device manufacturing?
Costa Rica combines a skilled workforce, an efficient business climate, and robust infrastructure, making it an ideal location for medical device manufacturing.
